ECTS and Mellanby Centre Training Course: Diagnostic Tests for Osteoporosis Clinical Use of Bone Turnover Markers
Bone Turnover Markers (BTM) have long been used as diagnostic tests for metabolic bone diseases. In the past 20 years, markers that are more specific to bone have been introduced and have been found to be useful in osteoporosis, particularly for monitoring treatment. This course aims to provide a background to the clinical use of bone turnover markers.
This day-long course is open to clinicians (e.g. endocrinology, rheumatology, care of the elderly and clinical chemistry), laboratory scientists and nurses involved in the clinical management of patients at risk of osteoporotic fractures.
At the end of the course, participants should:
- understand the process of bone remodelling and how this can be studied using BTM
- appreciate the methods used for measuring BTM and their sources of variability
- be able to identify the role of BTM in the diagnosis and monitoring of bone diseases in a number of clinical settings including; osteoporosis, chronic kidney disease, Paget’s disease, osteomalacia, and GIOP,.
- be familiar with best practice in the clinical use of BTM
Endorsement and Accreditation:
Applications for credits points will be submitted to the Swiss Societies for Endocrinology, Internal Medicine, Rheumatology, Physical Medicine and Rehabilitation, Gynecology and Laboratory Medicine as well as the DVO (Dachverband deutschsprachiger osteologischer Gesellschaften). Endorsement will be sought from the Association for Endocrinology, Rheumatology, Clinical Biochemistry and Laboratory Medicine, the Swiss Society against Osteoporosis and the Swiss Bone and Mineral Society and the DVO.
Chairman Richard Eastell (Sheffield, UK)
08:45-09:30 REGISTRATION AND COFFEE
09:30-09:35 BONE TURNOVER MARKERS: AN INTRODUCTION Richard Eastell (Sheffield, UK)
09:35-10:05 BONE REMODELLING AND THE INTERPRETATION OF BONE TURNOVER MARKER (BTM) RESULTS Richard Eastell (Sheffield, UK)
10:05-10:35 PRACTICAL ASPECTS OF MEASUREMENT AND SELECTION OF MARKER Marius Kraenzlin (Basel, CH)
10:35-11:05 SOURCES OF VARIABILITY IN BTM Christian Meier (Basel, CH)
11:05-11:30 COFFEE BREAK
11:30-12:00 USE OF BTM IN OSTEOPOROSIS: SHARED CARE PROTOCOLS IN PRIMARY CARE Jennie Walsh (Sheffield, UK)
12:00-13:00 INTERACTIVE WORKSHOPS
GROUP A: PROTOCOLS AND CASE EXAMPLES FOR THE USE OF BTM IN OSTEOPOROSIS PRACTICE
Jennie Walsh (Sheffield, UK), Christan Meier (Basel, CH)
GROUP B: USING BTM FOR OSTEOPOROSIS TREATMENT: RESEARCH APPLICATION
Marius Kraenzlin (Basel, CH), Richard Eastell (Sheffield, UK)
13:40-14:40 METABOLIC BONE DISEASES IN ADULTS Eugene McCloskey (Sheffield, UK)
14:40-15:30 METABOLIC BONE DISEASE OF CHRONIC KIDNEY DISORDER Barbara Obermayer-Pietsch (Graz, A)
15:30-15:50 COFFEE BREAK
15:50-16:50 INTERACTIVE WORKSHOPS
GROUP A: PROTOCOLS FOR THE USE OF BTM IN OSTEOPOROSIS PRACTICE
Jennie Walsh (Sheffield, UK), Christian Meier (Basel, CH)
GROUP C: USING BTM IN METABOLIC BONE DISEASE
Barbara Obermayer-Pietsch (Graz, A), Eugene McCloskey (Sheffield, UK)
17:10-17:30 EXPERT PANEL: QUESTIONS AND ANSWERS All speakers
17:30 CLOSE OF DAYRegister